-+ 0.00%
-+ 0.00%
-+ 0.00%

Amrize Chief Strategy Officer Buys 2,510 Shares in $117,769 Transaction

The Motley Fool·08/27/2026 22:15:01
Listen to the news

Key Points

  • The purchase involved 2,510 shares at $46.92 per share.

  • The shares were acquired directly, with no reported indirect holdings or derivative conversions.

  • The stock price has underperformed in 2026, falling 14.7%.

Samuel Jonas Poletti, Chief Strategy & M&A Officer at Amrize (NYSE:AMRZ), purchased 2,510 shares of the company on Aug. 17, 2026, according to a SEC Form 4 filing.

Transaction summary

Metric Value
Transaction value $117,769
Shares purchased 2,510
Post-transaction shares (directly held) 10,155
Post-transaction value $464,388

Transaction value based on SEC Form 4 weighted average purchase price ($46.92); post-transaction value based on Aug. 17, 2026 market close ($45.73).

Key questions

  • How does this transaction affect the officer's total equity position?
    Poletti expanded his direct ownership from 7,645 shares to 10,155 shares, with no additional shares held through indirect entities.
  • What was the market context on the day of the trade?
    The executive purchased shares at $46.92 per share, while the stock closed that same day at $45.73, following a 11% one-year loss as of the Aug. 17, 2026, transaction date.
  • Were there any unique jurisdictional or currency factors in the execution?
    The purchase was originally settled in Swiss Francs at CHF 37.97 per share and converted to U.S. dollars at an exchange rate of 0.8092 CHF per USD.
  • What is the insider's resulting ownership stake relative to the total company?
    Following this 33% increase in personal holdings, the officer's direct position represents 0.001% of the company's outstanding shares.

Company Overview

Metric Value
Share Price (as of market close 2026-08-17) $45.73
Market Capitalization $24.2 billion
Revenue (TTM) $12.2 billion
Net Income (TTM) $1.2 billion

Company Snapshot

  • Amrize provides comprehensive building solutions across two primary segments: Building Materials, which encompasses cement, aggregates, ready-mix concrete, and asphalt products, and Building Envelope, which delivers advanced roofing and wall systems, including single-ply membranes and insulation products.
  • The company generates revenue through the supply and distribution of construction materials and systems to infrastructure, commercial, and residential construction markets, leveraging its dual-segment operational structure to serve diverse customer needs across North America and Canada.
  • Amrize serves a broad customer base, including construction contractors, builders, developers, and infrastructure project owners across North American markets, positioning itself as a comprehensive solutions provider for the construction industry.

Amrize operates as a leading construction materials provider with a market capitalization of $24.2 billion and annual revenue of $12.2 billion (TTM), serving the essential infrastructure and construction sectors across North America. The company's dual-segment business model, which combines commodity-based building materials with higher-margin engineered building envelope systems, provides operational diversification and exposure to both cyclical and defensive construction end-markets. With 19,000 employees and established operations across North America and Canada, Amrize maintains a competitive position through integrated supply chains and comprehensive product offerings that address the full spectrum of construction material requirements.

What this transaction means for investors

The Amrize stock price has struggled to find its footing over the last year, with shares down 14.7%. In comparison, during the same period, the S&P 500 is up 19.2%. In the company's 2026 second-quarter earnings call, management pointed to issues with higher costs for diesel, freight, and materials, which are impacting profitability. However, Poletti's share purchase could be viewed as a bullish signal for shareholders. It could be a sign that, while the company is facing certain cost pressures now, the insider believes those will eventually subside. That's backed up by the number of shares Poletti bought (2,510), which increased his stake by 33%.

To pair with the insider's recent purchase, analysts are slightly bullish on Amrize. Of the 27 who cover the stock, 59% have a buy rating, 37% a hold, and 4% a sell, according to CNN. From those 27 analysts, the median one-year price target is $57, which would be a 28.7% from the stock price as of this writing. The highest price target in the group is $70, and even the lowest, $48, would still be a gain over the current price.

Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.